拉泽斯对堕胎和堕胎药物的见解与现代概念有关
Mohammad Amrollahi-Sharifabadi1, Jamal Rezaei Orimi2,3, Syed Mohd Abbas Zaidi4
1Department of Basic Sciences, Faculty of Veterinary Medicine, Lorestan University, 5th Kilometer of Khorramabad-Boroujerd Highway, Khorramabad, 68151-44316, Iran. amrollahi.m@lu.ac.ir.
Naunyn-Schmiedeberg's archives of pharmacology
|December 12, 2024
概括
拉塞斯 (Rhazes) 是一个拉塞斯人.
科学领域:
- 医学史 医学史 的历史
- 药理学 药理学是指药理学的学科.
- 产科和妇科 产科和妇科
背景情况:
- 堕胎是孕产妇死亡的一个重要原因,也是公众健康问题.
- 拉泽斯的"Kitab al-Ḥāwī fī al-Ṭibb"是医学史上的一个开创性的著作.
- 了解关于堕胎的历史观点对于当代实践至关重要.
研究的目的:
- 在 Kitāb al-Ḥāwī fī al-Ṭibb. 中分析Rhazes关于堕胎和堕胎植物的观点.
- 为了识别Rhazes提到的具有堕胎性质的药用植物.
- 通过当前的文学来探索Rhazes的洞察力潜在的科学理由.
主要方法:
- 详细的文字分析Rhazes的Kitab al-Ḥāwī fī al-Ṭibb. 这是一本书.
- 关键词检查侧重于堕胎,死胎,胎儿,药物和堕胎剂.
- 交叉引用历史发现与当前的科学文献.
主要成果:
- 拉齐斯讨论了堕胎,其预防和管理,为产科和妇科做出了贡献.
- 确定了各种药用植物具有潜在的堕胎性质.
- 描述了各种各样的施用方法,包括口服,阴道,,脱等.
结论:
- 拉泽斯的工作提供了对堕胎管理和草药剂的历史见解.
- 需要进一步的基于证据的研究和随机临床试验.
- 严格评估Rhazes描述的方法和药物的有效性和安全性是必不可少的.
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Physiological Barriers
3.4K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.4K
Factors Affecting Drug Distribution: Physiological Barriers
173
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
173
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
CRISPR
49.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.4K
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K


